Pages that link to "Q42453141"

The following pages link to Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1alpha,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer. (Q42453141):

Displaying 23 items.

• Regulation of the cytosolic sulfotransferases by nuclear receptors (Q26997383) (← links)
• Predicting binding to p-glycoprotein by flexible receptor docking (Q28478693) (← links)
• Discovery of novel vitamin D-regulated proteins in INS-1 cells: a proteomic approach (Q28854272) (← links)
• Impairment of bilirubin clearance and intestinal interleukin-6 expression in bile duct-ligated vitamin D receptor null mice (Q34512542) (← links)
• Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine (Q36272752) (← links)
• 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells (Q36512766) (← links)
• Interplay between vitamin D and the drug metabolizing enzyme CYP3A4 (Q36545257) (← links)
• No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers. (Q37009574) (← links)
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. (Q37121662) (← links)
• Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions (Q37130938) (← links)
• Drug-vitamin D interactions: a systematic review of the literature (Q38073239) (← links)
• Genetically Modified Caco-2 Cells With Improved Cytochrome P450 Metabolic Capacity. (Q38794808) (← links)
• Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products. (Q38974893) (← links)
• The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance (Q39580164) (← links)
• 1α,25-dihydroxyvitamin D3 on intestinal transporter function: studies with the rat everted intestinal sac. (Q42749433) (← links)
• Vitamin D and drug-metabolising enzymes (Q47247668) (← links)
• Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells (Q47286324) (← links)
• Vitamin D receptor activation induces P-glycoprotein and increases brain efflux of quinidine: an intracerebral microdialysis study in conscious rats (Q48484054) (← links)
• Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells (Q50069433) (← links)
• CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy (Q51072700) (← links)
• Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. (Q54268934) (← links)
• Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D3 : Effects on in vivo oral absorption and disposition of buspirone in rats (Q90403965) (← links)
• Intestinal P-gp and Putative Hepatic OATP1B Induction: ITC Perspective on Drug Development Implications (Q95925630) (← links)